Condition

Synucleinopathy

ClinicalTrials.gov condition label

Clinical trials3

Recruiting2

Common interventions9

Lead sponsors shown3

Clinical trials

3 shown

Tenapanor in Synucleinopathy-Related ConstipationNCT06460038 · 2025-01-01

The Swedish BioFINDER Sleep StudyNCT07533799 · 2021-10-01

Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological MatricesNCT07480187 · 2023-05-20

ACTIVE_NOT_RECRUITING

Common interventions

[123I] MIBG scintigraphy of the heartDIAGNOSTIC_TEST1 biomarkersDIAGNOSTIC_TEST1 Dopamine transporter PET scan with [18F]FE-PE2IDIAGNOSTIC_TEST1 Magnetic resonance imaging (MRI)DIAGNOSTIC_TEST1 PlaceboDRUG1 PolysomnographyDIAGNOSTIC_TEST1 Smell testDIAGNOSTIC_TEST1 TenapanorDRUG1 α-synuclein seeding amplification assaysDIAGNOSTIC_TEST1

Leading sponsors

Azienda Ospedaliera di Perugia1 Cedar Valley Digestive Health Center1 Skane University Hospital1

Trial status mix

RECRUITING2

ACTIVE_NOT_RECRUITING1

Phase mix

NA1

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.